PODD250117C390000
- 0.00
- 0.000.00%
Insulet Newsroom
First Earnings Show Beats are Back, December Jobs Climbed but Market Falls Friday | Live Stock
Press Release: Insulet to Announce Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025
Bernstein Maintains Insulet(PODD.US) With Buy Rating, Raises Target Price to $315
S&P 500 Positive for 'First Five Days,' Huang Sees Decades till Quantum | Wall Street Today
Wednesday Market Falls, Quantum Computing Pulls Back Hard on Treasury Yield Crunch | Live Stock
Bernstein Maintains Insulet(PODD.US) With Buy Rating, Raises Target Price to $305
Diabetes Device Maker Beta Bionics Files for $100M IPO
Tuesday Market Pulls Back After Nvidia All Time High | Wall Street Today
Citi Says 'Buy' These Stocks in '25; SA Quant Ratings Says Maybe Not
Market Sells CES Tech News, ISM Tuesday as Nvidia Champions Robots Monday | Live Stock
BofA Securities Maintains Insulet(PODD.US) With Buy Rating, Announces Target Price $305
Bank of America Securities Keeps Their Buy Rating on Insulet (PODD)
Market Climbed Monday Just Past Santa Rally High Water Mark | Wall Street Today
High Quality Cyclical Stocks According to Morgan Stanley
CES Tech Conference Week Starts with Nvidia and Chips Climbing | Live Stock
Express News | Insulet Corp : UBS Raises Target Price to $280 From $253
Wearable Patch Market Report 2025, With Profiles of Key Players Abbott, Medtronic, Dexcom, GlucoWatch, IRhythm Technologies, Insulet, Tactile Medical, VitalConnect, Qardio Myant & BioTelemetry
Here Are J. P. Morgan's Top MedTech Picks for 2025
If You Invested $100 In This Stock 10 Years Ago, You Would Have This Much Today
Santa Clause Came and Went Without Bringing Gifts | Weekly Buzz